These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8605919

  • 1. Immunization with glycosylated Kb-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells.
    Abdel-Motal UM, Berg L, Rosén A, Bengtsson M, Thorpe CJ, Kihlberg J, Dahmén J, Magnusson G, Karlsson KA, Jondal M.
    Eur J Immunol; 1996 Mar; 26(3):544-51. PubMed ID: 8605919
    [Abstract] [Full Text] [Related]

  • 2. Carrier-reactive hapten-specific cytotoxic T lymphocyte clones originate from a highly preselected T cell repertoire: implications for chemical-induced self-reactivity.
    Martin S, Ruh H, Hebbelmann S, Pflugfelder U, Rüde B, Weltzien HU.
    Eur J Immunol; 1995 Oct; 25(10):2788-96. PubMed ID: 7589073
    [Abstract] [Full Text] [Related]

  • 3. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition.
    Haurum JS, Tan L, Arsequell G, Frodsham P, Lellouch AC, Moss PA, Dwek RA, McMichael AJ, Elliott T.
    Eur J Immunol; 1995 Dec; 25(12):3270-6. PubMed ID: 8566011
    [Abstract] [Full Text] [Related]

  • 4. Glycopeptides bind MHC molecules and elicit specific T cell responses.
    Harding CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER.
    J Immunol; 1993 Sep 01; 151(5):2419-25. PubMed ID: 8360471
    [Abstract] [Full Text] [Related]

  • 5. Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides.
    Martin S, Ortmann B, Pflugfelder U, Birsner U, Weltzien HU.
    J Immunol; 1992 Oct 15; 149(8):2569-75. PubMed ID: 1383319
    [Abstract] [Full Text] [Related]

  • 6. Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins.
    Wang M, Bai F, Pries M, Buus S, Prause JU, Nissen MH.
    Invest Ophthalmol Vis Sci; 2006 Sep 15; 47(9):3939-45. PubMed ID: 16936108
    [Abstract] [Full Text] [Related]

  • 7. Mapping of epitopes recognized by alloreactive cytotoxic T lymphocytes using inhibition by MHC peptides.
    Heath WR, Vitiello A, Sherman LA.
    J Immunol; 1989 Sep 01; 143(5):1441-6. PubMed ID: 2474598
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with T cell receptor peptides primes anti-receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL.
    Kuhröber A, Schirmbeck R, Reimann J.
    Eur J Immunol; 1994 May 01; 24(5):1172-80. PubMed ID: 7514132
    [Abstract] [Full Text] [Related]

  • 9. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization.
    Abdel Motal UM, Zhou X, Joki A, Siddiqi AR, Srinivasa BR, Stenvall K, Dahmén J, Jondal M.
    Eur J Immunol; 1993 Dec 01; 23(12):3224-9. PubMed ID: 8258337
    [Abstract] [Full Text] [Related]

  • 10. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM, Schell TD, Shepherd SE, Klimo GF, Kioschos JM, Paterson Y.
    Eur J Immunol; 1994 Sep 01; 24(9):2141-9. PubMed ID: 7522163
    [Abstract] [Full Text] [Related]

  • 11. MUC1 peptide epitopes associated with five different H-2 class I molecules.
    Apostolopoulos V, Haurum JS, McKenzie IF.
    Eur J Immunol; 1997 Oct 01; 27(10):2579-87. PubMed ID: 9368613
    [Abstract] [Full Text] [Related]

  • 12. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
    De Bruijn ML, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ.
    Eur J Immunol; 1991 Dec 01; 21(12):2963-70. PubMed ID: 1660811
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
    Anjuère F, Horvath C, Cerottini JC, Luescher IF.
    Eur J Immunol; 1995 Jun 01; 25(6):1535-40. PubMed ID: 7614979
    [Abstract] [Full Text] [Related]

  • 15. Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.
    Lipford GB, Bauer S, Wagner H, Heeg K.
    Immunology; 1995 Feb 01; 84(2):298-303. PubMed ID: 7751006
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
    Speiser DE, Kyburz D, Stübi U, Hengartner H, Zinkernagel RM.
    J Immunol; 1992 Aug 01; 149(3):972-80. PubMed ID: 1634779
    [Abstract] [Full Text] [Related]

  • 18. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI, Stanziale SF, Lunin SD, Zaremba S, Schlom J.
    Eur J Immunol; 1996 Feb 01; 26(2):435-43. PubMed ID: 8617315
    [Abstract] [Full Text] [Related]

  • 19. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
    Sijts AJ, Ossendorp F, Mengedé EA, van den Elsen PJ, Melief CJ.
    J Immunol; 1994 Jan 01; 152(1):106-16. PubMed ID: 8254184
    [Abstract] [Full Text] [Related]

  • 20. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ, Boes J, Melief CJ.
    J Immunol; 1984 Jul 01; 133(1):24-7. PubMed ID: 6202782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.